GlassScriptPhysician profile
David A Garfinkel
NPI 1760476899
$4,805.44
in general payments reported to CMS, 2019-2025
29 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,937 · 2020: $1,194 · 2021: $798 · 2022: $226 · 2023: $453 · 2024: $82.65 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,815.00 | 2019-2022 | |
| Daiichi Sankyo INC. | $207.77 | 2019-2022 | |
| Abbvie INC. | $199.94 | 2019-2023 | |
| Coopersurgical, INC. | $174.86 | 2019-2024 | Summit Doppler, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $165.54 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $141.35 | 2021-2023 | |
| Hologic Sales and Service, LLC | $128.04 | 2019-2024 | Coolseal Generator, Aptima |
| Medtronic, INC. | $108.90 | 2021-2023 | Sonicision |
| Allergan, INC. | $104.88 | 2019-2020 | |
| Therapeuticsmd, INC. | $104.81 | 2019-2022 | |
| Avion Pharmaceuticals | $81.60 | 2019-2023 | Balcoltra |
| Pfizer INC. | $76.03 | 2021-2023 | |
| Myovant Sciences INC. | $50.33 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $49.99 | 2019-2020 | |
| Exeltis, USA INC. | $44.68 | 2020-2024 | Slynd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $44.38 | 2023-2024 | Veozah |
| Molnlycke Health Care US, LLC | $43.75 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Vertical Pharmaceuticals, LLC | $39.62 | 2019-2020 | |
| Organon LLC | $35.21 | 2023 | Jada System, Nexplanon |
| Agile Therapeutics, INC. | $29.68 | 2021 | |
| Amgen INC. | $29.53 | 2019-2020 | |
| Millicent US INC | $25.88 | 2019 | |
| Roche Diagnostics Corporation | $20.00 | 2020 | |
| Meditrina | $15.46 | 2023 | |
| Sumitomo Pharma America, INC. | $15.00 | 2023 | Myfembree |
| Sage Therapeutics, LLC | $15.00 | 2019 | |
| Merck Sharp & Dohme LLC | $13.28 | 2022 | |
| Minerva Surgical, INC | $13.20 | 2021 | |
| Duchesnay USA Incorporated | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Garfinkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.